What is the projected market valuation for the Companion Diagnostics for Oncology Market in 2035?

The projected market valuation for the Companion Diagnostics for Oncology Market in 2035 is 12.5 USD Billion. Read More

What was the market valuation for Companion Diagnostics for Oncology in 2024?

The market valuation for Companion Diagnostics for Oncology in 2024 was 5.713 USD Billion. Read More

What is the expected CAGR for the Companion Diagnostics for Oncology Market from 2025 to 2035?

The expected CAGR for the Companion Diagnostics for Oncology Market during the forecast period 2025 - 2035 is 7.38%. Read More

Which companies are considered key players in the Companion Diagnostics for Oncology Market?

Key players in the Companion Diagnostics for Oncology Market include Roche, Thermo Fisher Scientific, Abbott Laboratories, and Illumina. Read More

How much is the Next Generation Sequencing segment projected to grow by 2035?

The Next Generation Sequencing segment is projected to grow from 1.5 USD Billion in 2024 to 3.5 USD Billion by 2035. Read More

What applications are driving growth in the Companion Diagnostics for Oncology Market?

Applications driving growth include Predictive Testing, Therapeutic Monitoring, Patient Stratification, and Disease Diagnosis. Read More

What is the projected value of the Predictive Testing application by 2035?

The projected value of the Predictive Testing application is expected to reach 4.0 USD Billion by 2035. Read More

What is the expected growth for the Diagnostic Laboratories segment by 2035?

The Diagnostic Laboratories segment is expected to grow from 1.8 USD Billion in 2024 to 4.0 USD Billion by 2035. Read More

Companion Diagnostics Oncology Market

Q: What are the main technology segments in the Companion Diagnostics for Oncology Market?

The main technology segments include Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, and Immunohistochemistry. Read More

Q: Which end users are primarily involved in the Companion Diagnostics for Oncology Market?

Primary end users include Hospitals, Diagnostic Laboratories, Research Institutions, and Pharmaceutical Companies. Read More

Companion Diagnostics for Oncology Market Research Report: Size, Share, Trend Analysis By Technology (Next Generation Sequencing, Polymerase Chain Reaction, In Situ Hybridization, Immunohistochemistry), By Applicationss (Therapeutic Monitoring, Patient Stratification, Predictive Testing, Disease Diagnosis), By End Users (Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies), By Test Type (Genetic Tests, Protein Biomarker Tests, MicroRNA Tests, Pathological Analysis) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

7.38%

2024 Market Size

$ 5.71 Billion

2035 Market Size

$ 12.5 Billion

Medical Device ● Updated August 2026 Report ID: MRFR/MED/8942-CR | Pages: 200 | Author: Rahul Gotadki

Summary Table of Contents Segmentation Methodology Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Technology (USD Billion) | |
  1. 4.1.1 Next Generation Sequencing | |
  2. 4.1.2 Polymerase Chain Reaction | |
  3. 4.1.3 In Situ Hybridization | |
  4. 4.1.4 Immunohistochemistry |
2. 4.2 Healthcare, BY Applications (USD Billion) | |
  1. 4.2.1 Therapeutic Monitoring | |
  2. 4.2.2 Patient Stratification | |
  3. 4.2.3 Predictive Testing | |
  4. 4.2.4 Disease Diagnosis |
3. 4.3 Healthcare, BY End User (USD Billion) | |
  1. 4.3.1 Hospitals | |
  2. 4.3.2 Diagnostic Laboratories | |
  3. 4.3.3 Research Institutions | |
  4. 4.3.4 Pharmaceutical Companies |
4. 4.4 Healthcare, BY Test Type (USD Billion) | |
  1. 4.4.1 Genetic Tests | |
  2. 4.4.2 Protein Biomarker Tests | |
  3. 4.4.3 MicroRNA Tests | |
  4. 4.4.4 Pathological Analysis |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Roche (CH) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Thermo Fisher Scientific (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Abbott Laboratories (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Agilent Technologies (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Illumina (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Qiagen (DE) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Myriad Genetics (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Hoffmann-La Roche (CH) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 F. Hoffmann-La Roche (CH) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY TECHNOLOGY |
7. 6.4 US MARKET ANALYSIS BY APPLICATIONS |
8. 6.5 US MARKET ANALYSIS BY END USER |
9. 6.6 US MARKET ANALYSIS BY TEST TYPE |
10. 6.7 CANADA MARKET ANALYSIS BY TECHNOLOGY |
11. 6.8 CANADA MARKET ANALYSIS BY APPLICATIONS |
12. 6.9 CANADA MARKET ANALYSIS BY END USER |
13. 6.10 CANADA MARKET ANALYSIS BY TEST TYPE |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY TECHNOLOGY |
16. 6.13 GERMANY MARKET ANALYSIS BY APPLICATIONS |
17. 6.14 GERMANY MARKET ANALYSIS BY END USER |
18. 6.15 GERMANY MARKET ANALYSIS BY TEST TYPE |
19. 6.16 UK MARKET ANALYSIS BY TECHNOLOGY |
20. 6.17 UK MARKET ANALYSIS BY APPLICATIONS |
21. 6.18 UK MARKET ANALYSIS BY END USER |
22. 6.19 UK MARKET ANALYSIS BY TEST TYPE |
23. 6.20 FRANCE MARKET ANALYSIS BY TECHNOLOGY |
24. 6.21 FRANCE MARKET ANALYSIS BY APPLICATIONS |
25. 6.22 FRANCE MARKET ANALYSIS BY END USER |
26. 6.23 FRANCE MARKET ANALYSIS BY TEST TYPE |
27. 6.24 RUSSIA MARKET ANALYSIS BY TECHNOLOGY |
28. 6.25 RUSSIA MARKET ANALYSIS BY APPLICATIONS |
29. 6.26 RUSSIA MARKET ANALYSIS BY END USER |
30. 6.27 RUSSIA MARKET ANALYSIS BY TEST TYPE |
31. 6.28 ITALY MARKET ANALYSIS BY TECHNOLOGY |
32. 6.29 ITALY MARKET ANALYSIS BY APPLICATIONS |
33. 6.30 ITALY MARKET ANALYSIS BY END USER |
34. 6.31 ITALY MARKET ANALYSIS BY TEST TYPE |
35. 6.32 SPAIN MARKET ANALYSIS BY TECHNOLOGY |
36. 6.33 SPAIN MARKET ANALYSIS BY APPLICATIONS |
37. 6.34 SPAIN MARKET ANALYSIS BY END USER |
38. 6.35 SPAIN MARKET ANALYSIS BY TEST TYPE |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY TECHNOLOGY |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY APPLICATIONS |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USER |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY TECHNOLOGY |
45. 6.42 CHINA MARKET ANALYSIS BY APPLICATIONS |
46. 6.43 CHINA MARKET ANALYSIS BY END USER |
47. 6.44 CHINA MARKET ANALYSIS BY TEST TYPE |
48. 6.45 INDIA MARKET ANALYSIS BY TECHNOLOGY |
49. 6.46 INDIA MARKET ANALYSIS BY APPLICATIONS |
50. 6.47 INDIA MARKET ANALYSIS BY END USER |
51. 6.48 INDIA MARKET ANALYSIS BY TEST TYPE |
52. 6.49 JAPAN MARKET ANALYSIS BY TECHNOLOGY |
53. 6.50 JAPAN MARKET ANALYSIS BY APPLICATIONS |
54. 6.51 JAPAN MARKET ANALYSIS BY END USER |
55. 6.52 JAPAN MARKET ANALYSIS BY TEST TYPE |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY TECHNOLOGY |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY APPLICATIONS |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USER |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE |
60. 6.57 MALAYSIA MARKET ANALYSIS BY TECHNOLOGY |
61. 6.58 MALAYSIA MARKET ANALYSIS BY APPLICATIONS |
62. 6.59 MALAYSIA MARKET ANALYSIS BY END USER |
63. 6.60 MALAYSIA MARKET ANALYSIS BY TEST TYPE |
64. 6.61 THAILAND MARKET ANALYSIS BY TECHNOLOGY |
65. 6.62 THAILAND MARKET ANALYSIS BY APPLICATIONS |
66. 6.63 THAILAND MARKET ANALYSIS BY END USER |
67. 6.64 THAILAND MARKET ANALYSIS BY TEST TYPE |
68. 6.65 INDONESIA MARKET ANALYSIS BY TECHNOLOGY |
69. 6.66 INDONESIA MARKET ANALYSIS BY APPLICATIONS |
70. 6.67 INDONESIA MARKET ANALYSIS BY END USER |
71. 6.68 INDONESIA MARKET ANALYSIS BY TEST TYPE |
72. 6.69 REST OF APAC MARKET ANALYSIS BY TECHNOLOGY |
73. 6.70 REST OF APAC MARKET ANALYSIS BY APPLICATIONS |
74. 6.71 REST OF APAC MARKET ANALYSIS BY END USER |
75. 6.72 REST OF APAC MARKET ANALYSIS BY TEST TYPE |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY TECHNOLOGY |
78. 6.75 BRAZIL MARKET ANALYSIS BY APPLICATIONS |
79. 6.76 BRAZIL MARKET ANALYSIS BY END USER |
80. 6.77 BRAZIL MARKET ANALYSIS BY TEST TYPE |
81. 6.78 MEXICO MARKET ANALYSIS BY TECHNOLOGY |
82. 6.79 MEXICO MARKET ANALYSIS BY APPLICATIONS |
83. 6.80 MEXICO MARKET ANALYSIS BY END USER |
84. 6.81 MEXICO MARKET ANALYSIS BY TEST TYPE |
85. 6.82 ARGENTINA MARKET ANALYSIS BY TECHNOLOGY |
86. 6.83 ARGENTINA MARKET ANALYSIS BY APPLICATIONS |
87. 6.84 ARGENTINA MARKET ANALYSIS BY END USER |
88. 6.85 ARGENTINA MARKET ANALYSIS BY TEST TYPE |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TECHNOLOGY |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATIONS |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY TECHNOLOGY |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY APPLICATIONS |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY TECHNOLOGY |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY APPLICATIONS |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE |
102. 6.99 REST OF MEA MARKET ANALYSIS BY TECHNOLOGY |
103. 6.100 REST OF MEA MARKET ANALYSIS BY APPLICATIONS |
104. 6.101 REST OF MEA MARKET ANALYSIS BY END USER |
105. 6.102 REST OF MEA MARKET ANALYSIS BY TEST TYPE |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY APPLICATIONS, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY APPLICATIONS, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY END USER, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY TEST TYPE, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY TEST TYPE, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY TEST TYPE, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY TEST TYPE, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY TEST TYPE, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY TEST TYPE, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY TEST TYPE, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY TEST TYPE, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY TEST TYPE, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY TEST TYPE, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY TEST TYPE, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY TEST TYPE, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY TEST TYPE, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY TEST TYPE, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY TEST TYPE, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY TEST TYPE, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY TEST TYPE, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY TEST TYPE, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY TEST TYPE, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY TEST TYPE, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY TEST TYPE, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY TEST TYPE, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY TEST TYPE, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY TEST TYPE, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY TEST TYPE, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY TEST TYPE, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY TEST TYPE, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY TEST TYPE, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY TEST TYPE, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY TEST TYPE, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY TECHNOLOGY, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY APPLICATIONS, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY TEST TYPE, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Companion Diagnostics Oncology Market Segmentation

Companion Diagnostics Oncology Market By Technology (USD Billion, 2025-2035)

Next Generation Sequencing
Polymerase Chain Reaction
In Situ Hybridization
Immunohistochemistry

Companion Diagnostics Oncology Market By Applications (USD Billion, 2025-2035)

Therapeutic Monitoring
Patient Stratification
Predictive Testing
Disease Diagnosis

Companion Diagnostics Oncology Market By End User (USD Billion, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutions
Companion Diagnostics Oncology Market Companies

Companion Diagnostics Oncology Market By Test Type (USD Billion, 2025-2035)

Genetic Tests
Protein Biomarker Tests
MicroRNA Tests
Pathological Analysis

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”